Routine screening with MRI for breast cancer among young women is sufficient.
Screening mammography is not needed in addition to MRI for early detection in younger women who are at risk for breast cancer, according to a study presented at RSNA 2016.
Researchers in the Netherlands performed a retrospective review to determine if women younger than 40 who were at risk of breast cancer would benefit from supplemental mammography in addition to routine MRI screening.
The researchers analyzed 9,582 screening breast MRI examinations and 6,555 screening mammograms from 2,776 women who were screened between January 2003 to January 2014. Screening indication and age were obtained from patient records. These data were linked to the Netherlands Cancer Registry to identify all breast cancers. Of the cancers identified, imaging records were evaluated for mode and modality of detection.
The results showed that 179 cancers were identified, and 137 were screen detected; 13 by mammography alone. Eight of these cancers were ductal carcinoma in situ (DCIS) and the median age of the women was 55. Twelve of the breast cancers (92%) detected by mammography alone were found in women who were older than 40.
Three cancers (23%) were detected in BRCA mutation carriers, 5% of all screen detected cancers in BRCA mutation carriers, and two were diagnosed as DCIS in women older than 50.
The researchers concluded that adding mammography to screening MRI in younger women did not add value or detect more breast cancers. Added value for women over 40 is still limited, they added.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.